Researchers at Department of Haematology and Oncology Report Findings in ... HispanicBusiness.com Their experience showed that this drug is effective and manageable even when reused in both settings: chronic lymphocytic leukemia and non-Hodgkin's lymphomas combined with rituximab and/or mitoxantrone. The slow evolution in the treatment of patients ... |
